Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-09-25

Clinical Trial Update: RCT Comparing ESWT With PRP for Plantar Fasciitis in High Demand Cohort [NA]

View source ↗

Summary

A randomized trial comparing extracorporeal shock wave therapy (ESWT) and platelet-rich plasma (PRP) for plantar fasciitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Extracorporeal shock wave therapy (ESWT)
  • Platelet-rich plasma therapy (PRP)

Snippet

Sponsor: Edna Rath | Conditions: Fasciitis, Plantar | NA | Status: WITHDRAWN